| Literature DB >> 10439378 |
I Levi1, P Raanani, B Shalmon, R Schiby-Brilliant, I Ben-Bassat.
Abstract
All-trans-retinoic acid (ATRA) is considered the recommended induction treatment for acute promyelocytic leukemia (APL). Although the dermatological side effects associated with ATRA treatment are relatively common, acute neutrophilic dermatosis (Sweet's syndrome) has only been rarely reported. We describe such a case who responded to chemotherapy and not to low doses of corticosteroids.Entities:
Mesh：
Substances：
Year: 1999 PMID： 10439378 DOI： 10.3109/10428199909050966
Source DB: PubMed Journal: Leuk Lymphoma ISSN： 1026-8022